• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肝纤维化自发消退的机制。肝星状细胞凋亡及金属蛋白酶抑制剂肝表达降低。

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

作者信息

Iredale J P, Benyon R C, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur M J

机构信息

University Medicine, University of Southampton, Hampshire SO16 6YD, United Kingdom.

出版信息

J Clin Invest. 1998 Aug 1;102(3):538-49. doi: 10.1172/JCI1018.

DOI:10.1172/JCI1018
PMID:9691091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC508915/
Abstract

Liver fibrosis results from the excessive secretion of matrix proteins by hepatic stellate cells (HSC), which proliferate during fibrotic liver injury. We have studied a model of spontaneous recovery from liver fibrosis to determine the biological mechanisms mediating resolution. Livers were harvested from rats at 0, 3, 7, and 28 d of spontaneous recovery from liver fibrosis induced by 4 wk of twice weekly intraperitoneal injections with CCl4. Hydroxyproline analysis and histology of liver sections indicated that the advanced septal fibrosis observed at time 0 (peak fibrosis) was remodeled over 28 d of recovery to levels close to control (untreated liver). alpha-Smooth muscle actin staining of liver sections demonstrated a 12-fold reduction in the number of activated HSC over the same time period with evidence of HSC apoptosis. Ribonuclease protection analysis of liver RNA extracted at each recovery time point demonstrated a rapid decrease in expression of the collagenase inhibitors TIMP-1 and TIMP-2, whereas collagenase mRNA expression remained at levels comparable to peak fibrosis. Collagenase activity in liver homogenates increased through recovery. We suggest that apoptosis of activated HSC may vitally contribute to resolution of fibrosis by acting as a mechanism for removing the cell population responsible for both producing fibrotic neomatrix and protecting this matrix from degradation via their production of TIMPs.

摘要

肝纤维化是由肝星状细胞(HSC)过度分泌基质蛋白所致,肝星状细胞在纤维化肝损伤过程中会增殖。我们研究了肝纤维化自发恢复的模型,以确定介导纤维化消退的生物学机制。从经每周两次腹腔注射四氯化碳4周诱导肝纤维化的大鼠身上,在自发恢复的第0、3、7和28天采集肝脏。肝组织切片的羟脯氨酸分析和组织学检查表明,在第0天(纤维化高峰期)观察到的晚期间隔纤维化在28天的恢复过程中发生重塑,恢复到接近对照(未处理肝脏)的水平。肝组织切片的α-平滑肌肌动蛋白染色显示,在同一时期,活化的肝星状细胞数量减少了12倍,并有肝星状细胞凋亡的证据。对每个恢复时间点提取的肝脏RNA进行核糖核酸酶保护分析表明,胶原酶抑制剂TIMP-1和TIMP-2的表达迅速下降,而胶原酶mRNA表达仍维持在与纤维化高峰期相当的水平。肝匀浆中的胶原酶活性在恢复过程中增加。我们认为,活化的肝星状细胞凋亡可能通过作为一种机制来清除负责产生纤维化新基质并通过其产生TIMP保护该基质不被降解的细胞群体,从而对纤维化的消退起到至关重要的作用。

相似文献

1
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.大鼠肝纤维化自发消退的机制。肝星状细胞凋亡及金属蛋白酶抑制剂肝表达降低。
J Clin Invest. 1998 Aug 1;102(3):538-49. doi: 10.1172/JCI1018.
2
Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.金属蛋白酶组织抑制剂-1可减弱转基因小鼠自发性肝纤维化的消退。
Hepatology. 2002 Oct;36(4 Pt 1):850-60. doi: 10.1053/jhep.2002.35625.
3
Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.在实验性肝损伤和肝纤维化中,金属蛋白酶组织抑制因子-1信使核糖核酸的表达相对于间质胶原酶信使核糖核酸有所增强。
Hepatology. 1996 Jul;24(1):176-84. doi: 10.1002/hep.510240129.
4
[Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].[针刺对四氯化碳诱导的肝纤维化大鼠肝细胞外基质生成的抑制作用]
Zhen Ci Yan Jiu. 2012 Feb;37(1):8-14.
5
Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis.氯化钆增强库普弗细胞间质胶原酶(基质金属蛋白酶-13)的产生可预防猪血清诱导的大鼠肝纤维化。
Biochem Biophys Res Commun. 2000 Jan 7;267(1):290-5. doi: 10.1006/bbrc.1999.1910.
6
Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.靶向金属蛋白酶组织抑制剂-2的改良合成小干扰RNA抑制大鼠肝纤维化形成。
J Gene Med. 2007 Mar;9(3):217-29. doi: 10.1002/jgm.1009.
7
Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice.基质金属蛋白酶-9突变体对小鼠肝纤维化形成的抑制作用
FASEB J. 2006 Mar;20(3):444-54. doi: 10.1096/fj.05-4828com.
8
Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration.胶原蛋白-1中的突变赋予了对胶原酶作用的抗性,这导致四氯化碳诱导的肝纤维化无法恢复,活化的肝星状细胞持续存在,以及肝细胞再生减少。
FASEB J. 2003 Jan;17(1):47-9. doi: 10.1096/fj.02-0494fje. Epub 2002 Nov 15.
9
Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.金属蛋白酶组织抑制剂、肝星状细胞与肝纤维化
J Gastroenterol Hepatol. 1998 Sep;13 Suppl:S33-8.
10
Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.博来霉素诱导的肺纤维化中金属蛋白酶组织抑制剂-1的选择性诱导
Am J Respir Cell Mol Biol. 2001 May;24(5):599-607. doi: 10.1165/ajrcmb.24.5.4192.

引用本文的文献

1
CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease.晚期肝病小鼠模型中CD8 T细胞功能亢进与肿瘤控制减弱
Eur J Immunol. 2025 Aug;55(8):e70026. doi: 10.1002/eji.70026.
2
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的抗纤维化治疗
JHEP Rep. 2025 Apr 11;7(8):101421. doi: 10.1016/j.jhepr.2025.101421. eCollection 2025 Aug.
3
Biological Aging and Uterine Fibrosis in Cattle: Reproductive Trade-Offs from Enhanced Productivity.牛的生物衰老与子宫纤维化:生产力提高带来的生殖权衡
Cells. 2025 Jun 22;14(13):955. doi: 10.3390/cells14130955.
4
Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α: A study with an 11- to 173-month follow-up.聚乙二醇干扰素α治疗慢性乙型肝炎患者HBsAg清除后的临床结局:一项随访11至173个月的研究。
Virol Sin. 2025 Aug;40(4):579-586. doi: 10.1016/j.virs.2025.06.008. Epub 2025 Jul 4.
5
Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease.肝星状细胞:在健康与疾病中平衡体内稳态、肝脏保护和纤维化形成
Nat Rev Gastroenterol Hepatol. 2025 May 22. doi: 10.1038/s41575-025-01068-6.
6
Role of Essential Oils and Antioxidants in the Treatment of Fibrosis.精油和抗氧化剂在纤维化治疗中的作用
Curr Drug Res Rev. 2025;17(1):76-89. doi: 10.2174/0125899775271616231205111827.
7
Sex differences in diet-induced MASLD - are female mice naturally protected?饮食诱导的代谢相关脂肪性肝病中的性别差异——雌性小鼠天然受到保护吗?
Front Endocrinol (Lausanne). 2025 Mar 14;16:1567573. doi: 10.3389/fendo.2025.1567573. eCollection 2025.
8
Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction-Associated Steatohepatitis.代谢功能障碍相关脂肪性肝炎中肝星状细胞表型的调控
Gastroenterology. 2025 Mar 20. doi: 10.1053/j.gastro.2025.03.010.
9
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer.肝癌中肝星状细胞的功能异质性
Semin Liver Dis. 2025 Mar;45(1):33-51. doi: 10.1055/a-2551-0724. Epub 2025 Mar 5.
10
The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives.组织修复与再生中干细胞分泌组的范例:现状与未来展望。
Wound Repair Regen. 2025 Jan-Feb;33(1):e13251. doi: 10.1111/wrr.13251.

本文引用的文献

1
CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair.CD95/CD95L介导的肝星状细胞凋亡。一种在肝组织修复过程中终止肝星状细胞不受控制增殖的机制。
Am J Pathol. 1997 Nov;151(5):1265-72.
2
Localization and cellular sources of activins in normal and fibrotic rat liver.正常和纤维化大鼠肝脏中激活素的定位及细胞来源
Hepatology. 1997 Oct;26(4):905-12. doi: 10.1002/hep.510260416.
3
Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.在实验性肝损伤和肝纤维化中,金属蛋白酶组织抑制因子-1信使核糖核酸的表达相对于间质胶原酶信使核糖核酸有所增强。
Hepatology. 1996 Jul;24(1):176-84. doi: 10.1002/hep.510240129.
4
A license to kill.杀人执照。
Cell. 1996 Jun 14;85(6):781-4. doi: 10.1016/s0092-8674(00)81005-3.
5
The molecular biology of apoptosis.细胞凋亡的分子生物学
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2239-44. doi: 10.1073/pnas.93.6.2239.
6
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.金属蛋白酶组织抑制剂1和2在人肝纤维化组织中的表达增加。
Gastroenterology. 1996 Mar;110(3):821-31. doi: 10.1053/gast.1996.v110.pm8608892.
7
Apoptosis and the cell cycle.细胞凋亡与细胞周期
Curr Opin Cell Biol. 1995 Dec;7(6):825-34. doi: 10.1016/0955-0674(95)80066-2.
8
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.《波士顿贝斯以色列医院医学研讨会。肝纤维化的细胞基础。机制与治疗策略》
N Engl J Med. 1993 Jun 24;328(25):1828-35. doi: 10.1056/NEJM199306243282508.
9
C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis.C.L.奥克利讲座(1993年)。肝纤维化的细胞和分子层面
J Pathol. 1993 Jun;170(2):105-14. doi: 10.1002/path.1711700203.
10
Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.慢性肝病和肝细胞癌患者血清金属蛋白酶组织抑制剂
Clin Chim Acta. 1993 Sep 17;218(1):47-58. doi: 10.1016/0009-8981(93)90221-o.